Cagrilintide vs Tirzepatide: Single Compound vs Dual-Receptor Targeting
Tirzepatide (branded as Mounjaro and Zepbound) is a dual GIP/GLP-1 receptor agonist. A single molecule engineered to activate both incretin pathways with a single injection. Cagrilintide, by contrast, activates only amylin recept…